Guaifenesin 58602-0864
Product NDC
58602-0864- Manufacturer
- Aurohealth Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- March 11, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA210453
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Packaging Options(1)
5 BLISTER PACK in 1 CARTON (58602-864-98) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK